Literature DB >> 31153901

Regulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions.

Abel Soto-Gamez1, Wim J Quax2, Marco Demaria3.   

Abstract

Cellular senescence is a state of stable cell cycle arrest arising in response to DNA and mitochondrial damages. Senescent cells undergo morphological, structural and functional changes that are influenced by a number of variables, including time, stress, tissue, and cell type. The heterogeneity of the senescent phenotype is exemplified by the many biological properties that senescent cells can cover. The advent of innovative model organisms has demonstrated a functional role of senescent cells during embryogenesis, tissue remodeling, tumorigenesis and aging. Importantly, prolonged and aberrant persistence of senescent cells is often associated with tissue dysfunction and pathology, and is partially the consequence of mechanisms that enhance survival and resistance to cell death. Here, we describe the main molecular players involved in promoting survival of senescent cells, with particular emphasis on the regulation of senescence-associated anti-apoptotic pathways. We discuss the consequences these pathways have in providing resistance to intrinsic and extrinsic pro-apoptotic signals. Finally, we highlight the importance of these pathways in the development of targets for senolytic interventions.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  aging; apoptosis; cell death; cellular senescence

Mesh:

Year:  2019        PMID: 31153901     DOI: 10.1016/j.jmb.2019.05.036

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  39 in total

1.  GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.

Authors:  Rindert Missiaen; Nicole M Anderson; Laura C Kim; Bailey Nance; Michelle Burrows; Nicolas Skuli; Madeleine Carens; Romain Riscal; An Steensels; Fuming Li; M Celeste Simon
Journal:  Cell Metab       Date:  2022-07-14       Impact factor: 31.373

Review 2.  Cellular senescence in neuroblastoma.

Authors:  Sofia Zanotti; Bieke Decaesteker; Suzanne Vanhauwaert; Bram De Wilde; Winnok H De Vos; Frank Speleman
Journal:  Br J Cancer       Date:  2022-02-23       Impact factor: 9.075

Review 3.  The origins of cancer cell dormancy.

Authors:  Jorge Morales-Valencia; Gregory David
Journal:  Curr Opin Genet Dev       Date:  2022-04-29       Impact factor: 4.665

Review 4.  Targeting cellular senescence as a novel treatment for osteoarthritis.

Authors:  Emma M Astrike-Davis; Philip Coryell; Richard F Loeser
Journal:  Curr Opin Pharmacol       Date:  2022-04-18       Impact factor: 4.768

5.  Chromatin-Directed Proteomics Identifies ZNF84 as a p53-Independent Regulator of p21 in Genotoxic Stress Response.

Authors:  Anna Strzeszewska-Potyrała; Karolina Staniak; Joanna Czarnecka-Herok; Mahmoud-Reza Rafiee; Marcin Herok; Grażyna Mosieniak; Jeroen Krijgsveld; Ewa Sikora
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 6.  Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence.

Authors:  Jasper Iske; Tomohisa Matsunaga; Hao Zhou; Stefan G Tullius
Journal:  Front Immunol       Date:  2021-04-28       Impact factor: 7.561

7.  Senolytic treatment rescues blunted muscle hypertrophy in old mice.

Authors:  Cory M Dungan; Vandre C Figueiredo; Yuan Wen; Georgia L VonLehmden; Christopher J Zdunek; Nicholas T Thomas; C Brooks Mobley; Kevin A Murach; Camille R Brightwell; Douglas E Long; Christopher S Fry; Philip A Kern; John J McCarthy; Charlotte A Peterson
Journal:  Geroscience       Date:  2022-03-24       Impact factor: 7.713

Review 8.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

9.  Premature Senescence of T-cells Favors Bone Loss During Osteolytic Diseases. A New Concern in the Osteoimmunology Arena.

Authors:  Luis González-Osuna; Alfredo Sierra-Cristancho; Carolina Rojas; Emilio A Cafferata; Samanta Melgar-Rodríguez; Angélica M Cárdenas; Rolando Vernal
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

10.  Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.

Authors:  Nora Cazzagon; Samantha Sarcognato; Annarosa Floreani; Giorgia Corrà; Sara De Martin; Vincenza Guzzardo; Francesco Paolo Russo; Maria Guido
Journal:  JHEP Rep       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.